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Embryonic Stem Cell Research Controversy: 
Focus on the Private Sector and International 
Sphere 
Sylvia Kim· 
The latest developments in stem cell research have sparked more 
optimism and hope for people suffering from various maladies than any 
other recent medical or scientific breakthroughs. I Stem cell research holds 
the potential for treating virtually any disease and will eventually 
revolutionize the way patients are treated and cured? It holds enormous 
potential for finding cures for Parkinson's disease, heart disease, diabetes, 
and numerous neurological disorders.3 Until recently only animal stem 
cells were used in research, thus ethical issues had not become a grave 
concem.4 However, Dr. James Thomson at the University of Wisconsin 
and Dr. John Gearhart at Johns Hopkins University isolated and cultured 
human embryonic stem cells in 1998 by using privately funded 
laboratories.s This ignited the long-standing ethical debate on when life 
begins and the moral and ethical status of embryos. 
This Note demonstrates the following likely consequences of current 
federal and state regulations in the U.S. regarding stem cell research: (1) 
The U.S. will hinder important life-saving research; (2) such research will 
• J.D. Candidate, May 2002, University of California, Hastings College of the Law, B.A.. 
University of California. Berkeley (1997). I am deeply grateful to my husband, Doug Shin, 
for his continuing love and support. 
\. See Daniel Peny, Patients' Voices: The Powerful Sound in the Stem Cell Debate, 287 
SCIENCE 1423, 1423 (2000) (suggesting that new developments in stem cell research may 
help those suffering from various afflictions); James A. Thomson et aI., Embryonic Stem 
Cell Lines Derivedfrom Human B1astocysts, 282 SCIENCE 1145, 1145-47 (1998). 
2. See Stem Cell Research: Hearing Before the Subcomm. on Labor, Health & Human 
Servs., Educ., & Related Agencies of the Senate Comm. on Appropriations, 1 05 th Congo 9-10 
(1998) (prepared statement of Harold Varmus, M.D., Director, National Institutes of 
Health); Thomson, supra note 1, at 1145-46. 
3. See NATIONAL INSTITUTES OF HEALTH, STEM CELLS: SCIENTIFIC PROGRESS AND 
FU11JRE RESEARCH DIRECTIONS i (200 I ). 
4. Heather J. Kukla, Embryonic Stem Cell Research: An Ethical Justification, 90 GEO. 
L.J. 503, 504 (2002).. . 
5. National Institutes of Health, NIH Fact Sheet on Human Pluripotent Stem Cell 
Research Guidelines, at http://www.nih.gov/news/stemcell/stemfactsheet.htm (Jan. 2001). 
HASTINGS WOMEN'S LAW JOURNAL 89 
90 HASTINGS WOMEN'S LAW JOURNAL [Vol. 14:1 
continue with private funding without being scrutinized by the public 
ethical research review mechanisms; and (3) such research will continue in 
other countries as the U.S. is left behind the times. 
Part I of this Note examines the background information including the 
history and development of stem cell research. This part considers 
different ethical theories regarding using embryos in stem cell research 
starting with the source of controversy. It describes how stem cell research 
shows appropriate respect for embryos and concludes that the medical and 
scientific benefits expected from embryonic stem cell research justify using 
embryos. Part II discusses the current state of federal and state law on stem 
cell research. 
Part III focuses on the private sector of stem cell research and 
demonstrates the need for adequate safeguards and procedures to ensure 
that the research is conducted within ethical parameters in the private 
sector. Due to a lack of regulations other than in the funding context, 
privately funded research remains virtually unregulated. This part 
emphasizes the importance of using federal funding as an incentive to bring 
privately funded researchers into compliance with federal guidelines. 
Part IV addresses the global advances made in stem cell research while 
the U.S. federal government has been grappling with the ethical issues. 
Without federal funding, the private sector left to its own resources will 
only make slow progress compared to the rest of the world, and the U.S. 
will fall behind. 
Finally, the Note concludes that because withholding government 
funds from stem cell research does not eliminate moral and ethical 
objections, the U.S. should use federal funding to regulate the private 
sector and achieve faster and more efficient progress. Federal funding 
provides a solution for potential abuse in the unregulated, privately funded 
research and a way to keep up with the rest of the world while still ethically 
regulating the stem cell research. 
I. BACKGROUND: HISTORY AND DEVELOPMENT OF 
STEM CELL RESEARCH 
Embryonic stem cells have the unique ability to develop into all other 
types of human cells and "are capable of unlimited, undifferentiated 
proliferation in vitro.,,6 Although they cannot become an entire human 
being, they can renew themselves and form many different cell types and 
complex tissues. 7 They could be used in cell, tissue, or organ 
transplantation therapies, regeneration of brain tissues, restoration of 
6. National Institutes of Health, Stem Cells: A Primer, at http://www.nih.gov/news 
Istemceillprimer.htm (May 2000). 
7. Id. 
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nervous control, and safer testing of experimental drugs.8 The embryonic 
stem cells are derived from excess frozen embryos created at fertility 
treatment centers.9 The embryos are frozen at the blastocyst stage after 
sperm has fertilized the egg. IO 
A. SOURCE OF CONTROVERSY 
Human embryonic stem cell research is controversial because 
researchers must destroy the embryo in order to extract the stem cells. This 
research renewed discussions about the origins of human life, which were 
thoroughly examined in the context of abortion rights and embryonic 
research for infertility treatment." However, the embryonic specimens 
which researchers use in stem cell research are blastocysts, not fetuses. A 
blastocyst is a hollow sphere formed after a few days into the embryo's 
development after fertilization. 12 It is a cluster of cells that have 
proliferated for six to seven days after fertilization. 13 The outer cell mass 
eventually forms the placenta and the inner cell mass forms the human 
body of the embryo.14 The inner cells are able to develop into almost any 
cell type in the human body, although they do not have the ability to form 
the tissues supporting the embryo in the uterus. IS It is the inner cells that 
are extracted for embryonic stem cell research. 16 
Thus, the embryonic stem cell research only uses a portion of a cell 
cluster formed a few days after fertilization. "The bottom line has to be 
that these cells in and of themselves are not capable of [developing into a 
human without purposeful manipulation to achieve that end].,,17 
Additionally, cryopreservation, the freezing and storing of human 
embryos, further complicates the status of the embryos. 18 The frozen 
embryo is neither alive nor dead, but in a completely different state 
altogether. 19 
8. See National Institutes of Health, supra note 5. 
9. National Institutes of Health Guidelines for Research Using Human Pluripotent Stem 
Cells, 65 Fed. Reg. 51,976 (Aug. 25, 2000) (corrected at 65 Fed. Reg. 69,951 (Nov. 21. 
2000)). 
10. John A. Robertson, In the Beginning: The Legal Status of Early Embryos, 76 VA. L. 
REv. 437, 440 (1990). 
II. Kukla, supra note 4, at 507. 
12. National Institutes of Health, supra note 6. 
13. Id. 
14. Id. 
15. Id. 
16. Id. 
17. Gina Koiata, Cells Acting Like Embryos: Growing a Person From a Cell Begs the 
Question Where Life Begins, LONDON FREE PRESS, Apr. 17, 1999, at F7 (quoting Dr. John 
Gearhart of the Johns Hopkins University School of Medicine). 
18. Jason H. Casell, Lengthening the Stem: Allowing Federally Funded Researchers to 
Derive Human Pluripotent Stem Cells from Embryos, 34 U. MICH. J.L. REFORM 547, 556 
(2001). 
19. Id. 
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B. ETHICAL AND LEGAL ISSUES SURROUNDING RESEARCH 
1. The Special Nature of the Embryo 
The embryo is unique because it lacks cerebral activities that give rise 
to consciousness and neurological characteristics ascribed to humans in the 
special sense, despite exhibiting some characteristics of a living being.20 
Before determining whether embryonic stem cell research is ethically 
problematic, the moral status of the embryo needs to be explored. Three 
commonly articulated views provide a continuum on the status of the 
embryo.21 The first view treats embryos as human persons with the same 
moral status as a living person because the embryo has the potential to 
develop into a human being.22 This position, which is similar to the pro-
life view in the abortion debate,23 would prohibit all embryonic stem cell 
research.24 The second view asserts that embryos are merely clusters of 
cells without certain essential human capacities such as consciousness or 
sentience, and thus have no more moral status than any other human 
tissue.25 Under this view, almost no ethical limitations to stem cell research 
exist.26 
The third view resis in between the extremes.27 According to this view, 
embryos deserve "respect" even though they lack moral status as full 
human persons.28 However, the nature of respect for the embryos is subject 
to a wide range of interpretations because a precise definition does not 
exist. Although the National Bioethics Advisory Commission 
(Commission), a group that in 1999 studied ethical issues surrounding 
embryonic stem cell research at the direction of President Clinton, has 
stated that while "the human embryo. . . deserves respect as a form of 
human life, the scientific and clinical benefits of stem cell research should 
not be foregone,,,29 the Commission did not give a precise definition of 
respect.30 
The 1994 Human Embryo Research Panel (Panel) adopted the third 
20. See generally LEE SILVER, REMAKING EDEN: CLONING AND BEYOND IN A BRAVE NEW 
WORLD 41 (1997) (describing attributes of the embryo). 
21. I NATIONAL BIOETHICS ADVISORY COMMISSION, ETHICAL ISSUES IN HUMAN STEM 
CELL RESEARCH: REpORT AND RECOMMENDATIONS OF THE NATIONAL BIOETHICS ADVISORY 
COMMISSION 49 (1999), available at http://www.georgetown.eduJresearchinrcbllnbac 
Istemcell.pdf. 
22. ld. 
23. ld. 
24. Kukla, supra note 4, at 518. 
25. I NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at 49. 
26. Kukla, supra note 4, at 518-19. 
27. I NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at 50. 
28. Kukla, supra note 4, at 519. 
29. I NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at xi. 
30. ld. at 49-51. 
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view and stated that embryo research should proceed.31 The Panel 
articulated that the "preimplantation embryo" should receive serious moral 
consideration, but not the same consideration due infants or children.32 
They argue that the embryo, as a developing form of human life, deserves 
respect and . should be used in research only for the most serious and 
compelling reasons.33 The Commission also adopted this view.34 
2. Medical and Scientific Benefits 
Since the embryos deserve respect, but not full moral status, it becomes 
necessary to determine whether the benefits of stem cell research outweigh 
the respect due the embryo.35 To show respect for the embryo, the research 
needs to be conducted only as a means to a sufficiently important scientific 
or medical end.36 Embryonic stem cell research has demonstrated its 
potential to save numerous lives and alleviate suffering of many people. 
Surely, such scientific breakthroughs are "sufficiently important." 
Additionally, embryonic stem cell research falls along the "spectrum of 
morally acceptable options for disposing of embryos within the parameters 
of respect.,,3? 
The Commission articulated potential uses for embryonic stem cell 
research in 1999/8 and again in its June 2001 report issued at the request of 
the Bush Administration.39 Some of the medical and scientific benefits 
include possible treatment of diseases such as Parkinson's disease, 
Alzheimer's disease, heart disease, and kidney failure.4o The National 
Institutes of Health listed Parkinson's disease, diabetes, traumatic spinal 
cord injury, Purkinje cell degeneration, Duchenne's muscular dystrophy, 
heart failure, and osteogenesis imperfecta as diseases that could possibly be 
treated by transplanting cells derived from human embryonic cells.41 The 
National Institutes of Health concluded that stem cell research is 
"important to developing innovative cell replacement strategies to rebuild 
tissues and restore critical functions of the diseased or damaged human 
body.'>42 Furthermore, the medical and scientific communities estimate that 
over 100 million Americans are suffering from conditions that may be 
31. 1 NATIONAL INSTITUTES OF HEALTH, REPORT OF THE HUMAN EMBRYO RESEARCH 
PANEL 50 (1994). 
32. Id. 
33. Kukla, supra note 4, at 519. 
34. 1 NATIONALBIOETHICS ADVISORY COMMISSION, supra note 21, at xi. 
35. Kukla, supra note 4, at 521. 
36. Id. 
37. Id. 
38. See 1 NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at l. 
39. See NATIONAL INSTITUTES OF HEALTH, supra note 3, at 16-18. 
40. 1 NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at 1. 
41. NATIONAL INSTITUTES OF HEALTH, supra note 3, at 16. 
42. !d. at 11. 
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alleviated or cured through embryonic stem cell research.43 
The benefits of embryonic stem cell research are more than just 
speculative uncertainties. To list a few examples, researchers in Israel 
reported success in producing insulin with human embryonic stem cells in 
July 2001.44 In February 2001 researchers in the United States cured 
Parkinson's disease in laboratory animals using embryonic stem cells.45 
Considering such promising uses of stem cell research to cure various 
diseases, a compelling justification for stem cell research exists and it 
appears to be at least comparable to the respect embryos are due.46 
A strict utilitarian calculus or the moral imperative of compassion 
shows how the research may benefit people who are suffering.47 The 
alleviation of suffering and saving of lives balanced against the avoidance 
of harm to specific embryos by foregoing research yields. the conclusion 
that the benefits outweigh any harm. Thus, stem cell research should be 
allowed.48 However, this view has been criticized for devaluing human life 
at its earliest stage and thus possibly putting other vulnerable members of 
society at risk of being victimized by eugenics or euthanasia.49 The 
opponents argue that the value of the embryo needs to be considered 
beyond the utilitarian idea of "good for many" versus harm to one or a few 
embryos. 50 However, the high number of patients suffering from diseases 
that may be cured or treated through stem cell research more than justifies 
the research based on the moral imperative of compassion.51 Furthermore, 
patient groups urge that research should proceed because of the tremendous 
benefits to patients who suffer from diseases that could be alleviated 
through embryonic stem cell research.52 
Contrary to what stem cell research opponents proffer, embryonic stem 
cell research can show respect for the embryo, even though the embryo is 
destroyed in the process. 53 Four possible scenarios face the leftover 
embryos when excess embryos are created in fertility treatments: Donating 
43. Perry, supra note I, at 1423. 
44. Stem Cells Are Used to Produce Insulin, N.Y. TIMES, Aug. 1,2001, at A12. 
45. See Paul Recer, Parkinson's Disease: Possible 'Cure' in Political Arena, ATLANTA 
I.-CONST., Feb. 18,2001, at Cl. 
46. Kukla, supra note 4, at 523. 
47. See, e.g., Arthur Allen, God and Science, WASH. POST, Oct. 15,2000, (Magazine), at 
8; National Coalition for Cancer Survivorship, Media Alert, NCCS Joins Efforts of Patients' 
Cure to Advance Stem Cell Research, at http://www.cansearch.org/conferences/releases 
/pr052099.htm (May 20, 1999). 
48. Kukla, supra note 4, at 526. 
49. Frank E. Young, A Time for Restraint, 287 SCIENCE 1424, 1424 (2000). "The 
devaluation of humans at the very commencement of life encourages a policy of sacrificing 
the vulnerable that could ultimately put other humans at risk, such as those with disabilities 
and the aged, through a new eugenics or euthanasia." /d. 
50. Kukla, supra note 4, at 525. 
51. Id. 
52. /d. 
53. Id. at 526. 
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the embryo for gestation; permanently storing it; discarding it; or donating 
it for research.54 Gamete providers may consider the option of discarding 
the embryo or donating it for research only after they have eliminated the 
adoption and storage options voluntarily, without any input from 
researchers.55 Between the two options of discarding the embryo or 
donating it for research, more respect may be shown through research by 
alleviating the suffering of many people and possibly prolonging their 
lives. Using the embryo in research to benefit other suffering individuals is 
clearly an act that demonstrates valuing human life.56 "This promotes life 
in a way that simply discarding embryos, the source of potential alleviation 
of suffering, cannot.,,57 Even pro-life Republican Senator Orrin Hatch has 
stated that the stem cell research facilitates life and that helping people 
suffering from maladies is the most pro-life position, far more ethical than 
abandoning or discarding stem cells. 58 
3. Alternatives to Embryonic Stem Cell Research 
If alternatives can provide the same benefits as embryonic stem cell 
research it becomes harder to justify the use of embryos in light of the 
ethical controversy surrounding embryonic stem cell research. 59 If no 
alternative of equal potential exists, it should be easier for opponents to 
accept embryonic stem cell research.60 
Opponents of embryonic stem cell research have offered some 
alternatives. 61 One strong alternative is using adult stem cells instead of 
embryonic stem cells. 62 Adults have a small number of stem cells in 
certain types of tissues such as bone marrow or umbilical cord blood.63 
These stem cells can give rise to different types of cells in the body.64 For 
example, hematopoietic stem cells, found in bone marrow and umbilical 
cord blood, can tum into all types of blood cells in the adult human body.65 
Also, recent research revealed that mouse skeletal muscle cells could give 
rise to blood cells,66 and the use of bone marrow stem cells can repair heart 
damage in rodents that suffered heart attacks.67 
54. See I NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at 49. 
55. Kukla, supra note 4, at 529-30. 
56. Id. at 530. 
57. Id. 
58. Ceci Connolly, Conservative Pressure for Stem Cell Research Builds, WASH. POST, 
July 2, 2001, at AI. 
59. Kukla, supra note 4, at 531. 
60. Id. 
61. Id. 
62. Id. 
63. National Institutes of Health, supra note 6; Kukla, supra note 4, at 532. 
64. See National Institutes of Health, supra note 6. 
65. I NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at 12. 
66. Rick Weiss, In Cell 'Alchemy, ' an Alternative to Embryo Studies, WASH. POST, Apr. 
24,2000, at All. 
67. Nicholas Wade, Findings Deepen Debate on Using Embryonic Cells, N.Y. TiMES, 
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However, nobody has been able to prove that adult stem cell research 
will provide all the benefits of embryonic stem cell research.68 Rather, the 
National Institutes of Health researchers have concluded that stem cells in 
adult tissues do not have the same capacity to differentiate into all other 
types of cells as compared to embryonic stem cells.69 Additionally, other 
concerns including risks to the donor and the practicality of obtaining adult 
stem cells hinder the feasibility of adult stem cell research.7o Adult stem 
cells are riskier to retrieve, especially from brain or bone marrow/ 1 and 
they exist only in small quantities.72 They are harder to isolate/3 and their 
availability is likely to decrease with the donor's age.74 Also, researchers 
have expressed concerns about adult stem cells being genetically old; adult 
stem cells would have accumulated mutations and other damage throughout 
the donor's lifetime.7s Further, patients suffering from acute diseases 
would not have sufficient time to retrieve the cells from their own body and 
grow them in culture for successful treatment. 76 The embryo stem cells are 
better suited for research because they divide quickly and are capable of 
developing into almost all other types of cells in the body.77 
Another suggested alternative considers other sources for embryonic 
stem cells.7s Instead of using stem cells derived from spare embryos 
created for in vitro fertilization purposes, this option contemplates using 
stem cells derived from embryos created in vitro specifically for research 
purposes.79 However, this alternative has been criticized as not giving 
Apr. 3,2001, at Fl. 
68. Letter organized by the American Society for Cell Biology from Alliance for Aging 
Research et aI., to President-Elect George W, Bush (Jan, 17,200 1)( on file with author), 
69, NATIONAL INSTITUTES OF HEALTH, supra note 3, at ES-9, 
70. I NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at 57-59 (explaining 
that harvesting adult stem cells is difficult and risky to human beings and causes pain and 
discomfort); see also National Institutes of Health, supra note 6. "[Blrain cells from adults 
that may be neuronal stem cells have only been obtained by removing a portion of the brain 
of epileptics, not a trivial procedure." [d, 
71. See I NATIONAL B(OETH(CS ADVISORY COMMISS[ON, supra note 21, at 57-58 
(explaining that bone marrow extraction causes pain and discomfort and that brain biopsy 
poses significant risks to the donor), 
72, NATIONAL INSTITUTES OF HEALTH, supra note 3, at ES-6. 
73. !d. "[A]dult stem cells are dispersed in tissues throughout the mature animal and 
behave very differently." [d. at 23. 
74. National Institutes of Health, supra note 5, 
75. Weiss, supra note 66; see also National Institutes of Health, supra note 6 (noting that 
if a genetic defect caused the disorder in a patient, it may also be present in the patient's 
stem cells and that DNA mutations from exposure to toxins may be present in the stem 
cells). 
76. See Weiss, supra note 66, 
77. See Casell, supra note 18, at 551-52 (stating that embryonic stem cells can generate 
most of the specialized cells and tissue of the body and that adult stem cells may be able to 
divide only a limited number of times). 
78, Kukla, supra note 4, at 535. 
79, [d. 
Winter EMBRYONIC STEM CELL RESEARCH CONTROVERSY 97 
proper respect to embryos.80 Creating an embryo for reproduction is 
respectful of the embryo as a form of human life, but creating an embryo 
just for research purposes is not.81 This alternative violates the Kantian 
imperative of not using a person solely as a means to an end.82 In addition, 
this method devalues the sanctity of the procreative process and intent to 
create a child, and implies that the value of the embryo is found in its status 
as a research subject, not in its status as a symbol of human life.83 
As illustrated above, the suggested alternatives do not provide equal 
benefits, yet they are as ethically problematic as embryonic stem cell 
research. The benefits of adult stem cell research are insufficient to pursue 
adult stem cell research as an alternative to embryonic stem cell research. 
Deriving stem cells from embryos created for research purposes poses as 
serious, if not more serious, ethical problems. Considering these options, 
or lack thereof, proceeding with the embryonic stem cell research is the 
favorable option. 
II. CURRENT FEDERAL AND STATE LAW 
The latest controversy over stem cell research concerns the issue of 
whether federal funding should be available for research that uses existing 
embryonic stem cell lines, and not the derivation of new stem cells from 
early human embryos.84 Although federal law currently prohibits the 
funding of research that poses a risk to embryos,85 proponents of embryonic 
stem cell research argue that the ban does not apply to research that uses 
independently cultured stem cells, which are not embryos as defined by the 
Department of Health and Human Services.86 Federal funding has 
tremendous impact on the progress of embryonic' stem cell research. 
Embryonic stem cell research, in tum, has a potentially larger impact on the 
practice of medicine and the lives of people suffering from currently 
incurable diseases or conditions. Federal funding would ensure that both 
privately and publicly funded scientists have an opportunity to unlock the 
full potential of embryonic stem research. Perhaps the controversy exists 
because so much is at stake. 
80. Id at 537. 
81. Id. 
82. See I NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at 56 
(hypothesizing that the creation of embryos solely for research purposes will result in 
conceptualizing them as merely a means to an end). 
83. Kukla, supra note 4, at 538. 
84. Gabriel S. Gross, Federally Funding Human Embryonic Stem Cell Research: An 
Administrative Analysis, 2000 WIS. L. REv. 855, 860 (2000). 
85. See Omnibus Consolidated and Emergency Supplemental Appropriations Act, Pub. 
L. No. 105-277, § 511{a), 112 Stat. 2681 (1998). 
86. See National Institutes of Health, supra note 5 (explaining that the Department of 
Health and Human Services (DHHS) found that federal law does not prohibit DHHS funds 
from being used for research on human pluripotent cells because they are not embryos). 
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A. THE HISTORY OF FEDERAL POLICY ON HUMAN EMBRYO RESEARCH 
When Congress passed the National Institutes of Health Revitalization 
Act of 1993 ("Revitalization Act"), it amended the existing federal 
regulations governing research on human embryos.87 Prior to the 
amendment, federal regulations required such research to be reviewed and 
approved by an ethical advisory board before it might proceed.88 The 
Revitalization Act reversed the conditions for in vitro fertilization research 
by letting the research go forward unless disapproved.89 
In 1994, the National Institutes of Health and the Department of Health 
and Human Services convened an ethical advisory board, known as the 
Human Embryo Research Panel, and established standards for acceptable 
research for funding.90 Their report sparked controversy by concluding that 
researchers might ethically create embryos solely for research purposes 
through in vitro fertilization.91 Although the Advisory Committee formally 
approved the recommendations, President Clinton banned the use of federal 
funds for human embryo research and prohibited the National Institutes of 
Health from allocating any resources in 1994.92 Based on this presidential 
declaration, National Institutes of Health Director Harold Varmus 
concluded that embryonic stem cell research still might be funded if the 
embryos had been donated and not created solely for the purpose of 
research.93 
However, before the National Institutes of Health reached a funding 
decision, Congress attached a rider to that year's Department of Health and 
Human Services appropriation bill that effectively prohibited federal 
funding of any further human embryo research.94 
The rider to the appropriations bill, the Omnibus Consolidated and 
Emergency Supplemental Appropriations Act (OCESAA), states 
that none of the funds appropriated may be used to support 
research which involves: (1) creation of a human embryo or 
embryos for research purposes; or (2) research in which a human 
embryo or embryos are destroyed, discarded, or knowingly 
subjected to risk of injury or death greater than that allowed 
for research on fetuses m utero under 45 C.F.R. 
46.208(a)(2) and section 498(b) of the Public Health 
87. Doe v. Shalala, 862 F. Supp. 1421, 1424 (D.M.D. 1994). 
88. Jd. 
89. Jd. 
90. See id. at 1424-25; Meeting of Panel/Request for Public Comment, 59 Fed. Reg. 
28,874,28,875 (June 3, 1994). 
91. 1 NATIONAL BIOETHICS ADVISORY COMMISSlON, supra note 21, at 34. 
92. William J. Clinton, Statement on Federal Funding of Research on Human Embryos, 2 
PUB. PAPERS 19942142 (Dec. 2, 1994). 
93. Gross, supra note 84, at 865. 
94. Id. 
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Services Act (42 U.S.C. 289g(b».95 
Because embryonic stem cell research destroys the blastocyst in the 
process of extracting the stem cell, federal funds have not been allocated to 
support such research.96 However, the OCESAA rider did not ban the 
funding of embryo-related research that poses no risk to an embryo.97 
Research using embryonic stem cells already isolated from the embryo 
does not destroy or pose risk to an embryo.98 
In 1998, after breakthroughs in the field of embryonic stem cell 
research, President Clinton requested that the National Bioethics Advisory 
Commission review the medical and ethical issues surrounding human stem 
cell research.99 The National Bioethics Advisory Commission 
recommended responsible funding of such research,lOo and the Department 
of Health and Human Services issued its interpretation of federal law and 
opinion that funding embryonic stem cell research is permitted. 10 J 
B. THE DEPARTMENT OF HEALTH AND HUMAN SERVICES' 
INTERPRETATION OF FEDERAL REGULATIONS WITH RESPECT TO 
FUNDING EMBRYONIC STEM CELL RESEARCH 
Due to the highly charged political climate, the National Institutes of 
Health requested a legal opinion from the Department of Health and 
Human Services to determine whether research on embryonic stem cells 
would be considered research on embryos with respect to the federal 
funding ban. 102 In early 1999, the General Counsel for the Department of 
Health and Human Services opined that embryonic stem cells are not a 
human embryo within the statutory definitions. 103 The federal ban on 
human embryo research defines an embryo as an "organism" which is not 
already protected under Department of Health and Human Services 
regulations, but is derived by any process in which sperm meets egg. 104 
However, stem cells derived from the blastocyst are not an "organism" 
because they cannot become a fetus, even if implanted into a uterus. IOS 
95. Jd (citations omitted) (quoting Omnibus Consolidated and Emergency Supplemental 
Appropriations Act, Pub. L. No. 105-277, § 511(a), 112 Stat. 2681 (1998». 
96. Gross, supra note 84, at 866. 
97. Jd. 
98. Jd 
99. See 1 NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at Letter of 
Transmittal to the President. 
100. See id. (suggesting that limitations be placed on researchers who receive federal 
funds). 
WI. Gross, supra note 84, at 867. 
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These stem cells lack the capacity to become a fetus after they are extracted 
from an embryo. Therefore, they do not constitute an embryo once they are 
removed, resulting in destruction of the embryo.l06 Thus, the National 
Institutes of Health may fund embryonic stem cell research, provided that 
the research uses embryonic stem cells derived by privately funded 
researchers. 107 
In August 2000, the National Institutes of Health released guidelines on 
conducting stem cell research in an ethical manner. 108 These guidelines 
provided that, in order to obtain federal funding, embryonic stem cells must 
be derived from spare embryos from in vitro .fertilization treatments, not 
from embryos created for research purposes.109 The guidelines also 
prohibited the use of monetary inducements for the donation of embryos. 110 
In 200 I, the Bush Administration postponed a meeting of the Human 
Pluripotent Stem Cell Review Group to review the first applications for 
research grants under the new guidelines. III Although it was not clear 
whether Bush issued the order, the postponing of th.e meeting was viewed 
as the Bush Administration's intent to reconsider the issue of federal 
funding of embryonic stem cell research. I 12 A federal district court in the 
District of Columbia confirmed this halt in funding when it issued an order 
temporarily stopping federal funding until completion of the Bush 
Administration's review. I 13 In response to a request by the Bush 
Administration, the National Institutes of Health released its report, which 
is considered the most authoritative assessment of the medical and 
scientific potential, as well as uncertainties, of embryonic stem cell 
research. 114 The report concluded that stem cells from both adult sources 
and embryonic sources demonstrate tremendous potential for treating 
various diseases and conditions, and recommended that both types of 
research be allowed to proceed. ~ 15 
106. Kukla, supra note 4, at 508. 
107. JUDITH A. JOHNSON & BRIAN A. JACKSON, STEM CELL RESEARCH, CONGo RESEARCH 
SERVo REp. No. RS20523 (Sep. 19, 2000), available at http://www.cnie.org/nle/CRSreports 
/Science/st-53.cfm. 
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In August 200 I, President Bush finally decided to allow funding of 
embryonic stem cell research on existing stem cell lines where the life-and-
death decisions have already been made. 116 According to the National 
Institutes of Health estimates, over sixty stem cell lines existed in 2001. 117 
Consequently, federal funding is not available for research on any stem 
cells that had not been developed into cell lines at the time of Bush's 
announcement. 118 President Bush also mandated that a President's Council 
be established to monitor stem cell research. 119 
Although any funding is a significant step toward realizing the full 
potential of embryonic stem cell research, President Bush's decision 
received mixed reactions. 120 Some proponents of the research criticized the 
President for doing the bare minimum to publicly posture himself with the 
majority of Americans, but stopping short of full support for the 
research. 121 As of now, all of the regulations and statutes governing stem 
cell research pertain only to the funding context. 122 
C. STATE AND LOCAL LAWS 
Meanwhile, state legislatures have been actively involved in the 
embryonic .stem cell research debate. Almost two dozen states have 
enacted laws that address research on embryos and at least nine states ban 
all experimentation on human embryos.123 Some of the laws were enacted 
decades ago in response to the 1973 Supreme Court decision legalizing 
similarities and differences between the two types of cells). 
116. See Address to the Nation on Stem Cell Research from Crawford, Texas, 37 WEEKLY 
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abortion. 124 South Dakota went one step further, making it a misdemeanor 
to conduct non-therapeutic research on embryos at any stage. 125 This 
precludes any embryonic stem cell research. 126 
Also, some state statutes are broad enough to be interpreted to prevent 
payment for cell lines developed from embryonic stem cells,127 effectively 
prohibiting any stem cell research. Because the Department of Health and 
Human Services recommended that federally funded researchers should 
follow state and local laws, 128 researchers must comply with the laws of the 
state in which they conduct the research. As a result, the state statutes have 
carved out a significant place in the stem cell research regulation 
scheme. 129 
III. THE PRIV ATE SECTOR 
Because no federal regulations exist outside of the funding context, 
privately funded researchers are currently virtually unregulated. The recent 
breakthroughs in stem cell research such as the studies by the University of 
Wisconsin and Johns Hopkins University have all resulted from privately 
funded research projects. 130 These privately funded advances in research 
demonstrate that human stem cell research will occur in the private sector 
regardless of the availability of federal funding. I3l Although private 
research is hindered by economic limitations, the scope of private research 
is not restricted by the federal government. 132 
The Geron Corporation is a leading biotech company that supports 
three different research facilities nationwide. 133 As one of the forerunners 
in stem cell research, James Thomson at the University of Wisconsin in 
Madison has developed stem cell lines using private funds from Geron.134 
Thomson and his team of researchers isolated the stem cells from embryos 
and developed stem cell lines that retained the characteristics of human 
124. ld. (referring to Roe v. Wade, 410 U.S. 113 (l973)). 
125. S.D. CODIFIED LAWS §§ 34-14-16,34-14-20 (Michie Supp. 2001). 
126. ld.; Kukla, supra note 4, at 517. 
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possible that these laws which were intended to prohibit sale of embryonic tissue do not 
apply to cell lines created from embryonic stem cells since a "cell line is new tissue 
produced from the genetic material of, but not originally a part of, the embryo." Id. 
(quotation marks omitted). 
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131. ld. at 883. 
132. Shirley 1. Wright, Human Embryonic Stem-Cell Research: Science and Ethics, 87 
AM. SCIENTIST 352, 352 (1999) (noting that stem cell research is perfonned only by private 
companies without any institutional oversight). 
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L. REV. 1183, 1189 (2001). 
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embryonic stem cells. 135 Because these cells can multiply while remaining 
undifferentiated, Thomson has created a ready supply of stem cells without 
the need to sacrifice more embryos. Thus, ethical problems are minimized 
by Thomson's method. Geron acquired an enviable position of potentially 
controlling other research to some degree. 136 The advantage of possessing 
a ready supply of stem cells is especially significant considering President 
Bush's August 2001 announcement that funding would be available for 
embryonic stem cell research on existing stem cell lines only where the 
·life-and-death decisions have already been made. 
Two other leading research facilities funded by Geron include John 
Gearhart's team at Johns Hopkins University School of Medicine in 
Maryland, which utilizes primordial germ cells, and Roger Pedersen's team 
at University of California, San Francisco, which extracts stem cells from 
the inner cell mass of the blastocyst. 137 
Also at Johns Hopkins, Dr. Curt Civin has created various types of 
blood cells needed for treatment of certain blood diseases from adult bone 
marrow stem cells. 138 He has patented the techniques for separating and 
using bone marrow stem cells. 139 Dr. Civin is working toward using a 
patient's own stem cells to regenerate disease-free blood cells to replace 
bone marrow cells destroyed in treatment processes such as chemotherapy 
or radiation treatment for cancer. 140 Such technology may not only 
eliminate the danger of host rejection, Graft Versus Host Disease, or re-
infection of diseased cells involved .in procedures such as bone marrow 
transplant; 14 I it might very well produce cures for all kinds of blood 
diseases. 142 
Another researcher at Johns Hopkins, Dr. Jeffrey Rothstein, is 
experimenting with replacing damaged nerve cells in paralyzed lab 
animals. 143 With a goal of treating diseases like amyotrophic lateral 
sclerosis, which affects about 20,000 Americans, Dr. Rothstein intends to 
start feasibility and safety studies with human patients within the next three 
years. 144 
Advanced Cell Technology, another company actively involved in 
human genetic stem cell research, views cow and pig embryo stem cells as 
135. ld. 
136. Paegel, supra note 133, at 1190. 
137. Wright, supra note 132, at 354. 
138. See Johns Hopkins U. v. Cellpro, 931 F. Supp. 303, 308 (D. Del. 1996); Paegel, supra 
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140. ld. 
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a likely source for human organ transplants. 145 To make organs produced 
from cow and pig embryo stem cells compatible with humans, researchers 
are working on genetically altering animal embryonic stem cells. 146 The 
human body's natural rejection of foreign material stands as the biggest 
obstacle to successfully transplanting hearts or kidneys from pigs. 147 
Researchers are trying to genetically alter animal embryonic stem cells to 
generate cells that would be compatible with human tissue. 148 This type of 
research clearly falls outside the scope of federal funding guidelines 
recommended by the NIH because it entails "co-joining human and animal 
tissue.,,149 Thus, federal funding is not available for such research. 
However, as shown here, lack of federal funding has not dampened the 
private sector's spirit. 
Some researchers have even used cadavers in human stem cell 
research. 150 Fred H. Gage and other scientists at the Salk Institute in 
California are reviving neurons from ,dead brains by using cadaver brain 
stem cells. lSI Gage has also succeeded in extracting skin and bone stem 
cells and turning them into nerve cells. 152 He used tissues taken primarily 
from children soon after their death for these projects. IS3 
If research continues to proceed, through private funding it will 
potentially remain unregulated by the federal government and largely 
unknown to the public.154 The prospect of federal funding provides a 
strong incentive for privately funded independent research organizations to 
conform to federal guidelines and regulations to, obtain access to the vast 
resources of the federal government. 155 In return, compliance with federal 
guidelines and regulations offer the benefit of strictly enforced oversight 
processes which are absent in the privately funded research context. 156 The 
possibility of jointly funded projects by the government and private 
research institutions will reduce reliance on private funds and encourage 
compliance with federal regulations. 157 ' ' 
On the other hand, withholding federal funding from embryonic ste,m 
cell research would not resolve or forestall the moral and ethical objections 
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148. Wright, supra note 132, at 358-59. 
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expressed by the opponents of such research. It might even indirectly 
encourage unethical research practices. 15S Without federal funding and the 
essential checks and balances that accompany that funding, embryonic 
stem cell research will only continue in the private sector where it is not 
subject to government oversight. 159 The potential for unethical research 
could only increase in such an environment.. 
IV. THE GLOBAL RESPONSE TO STEM CELL RESEARCH 
The U.S. lags behind other countries in the embryonic human stem cell 
biotechnology race. 160 While the United States has been grappling with 
ethical issues, the rest of the· world has been busy moving forward with 
stem cell research, claiming their stake in this new frontier. 
In Scotland, where Dr. Ian Wilmut cloned Dolly the sheep, 
biotechnology companies and universities are discussing collaboration to 
clone embryos as a source of stem cells. 161 They are trying to assemble a 
team of commercial and academic partriers. Geron Corporation, an 
American company, is one of these partneis. 162 
Great Britain, one of the first countries to permit the use of human 
embryos in medical research,· publicly . announced that its Chief Medical 
Officer endorsed the use of embryonic stem cells for research into tissue 
and organ regeneration. 163 Although Parliament has yet to decide the issue, 
most experts believe it will decide in the favor of allowing such research. l64 
In Japan, the Council for Science and Technology, Japan's highest 
advisory group for science, is on the verge of approving guidelines for 
embryonic stem cell research: Researchers at Tokai University have 
already cloned a piglet successfully through xenotransplantation. These 
Japanese researchers believe that cloned pig organs can be transplanted to 
replace diseased human organs. . They· hope to genetically alter the 
immunological make-up in the cells that are used to create the clones to 
trick the human body into accepting pig transplants, thereby eliminating 
hostrejection. \65' . 
In France, Dr. Marc Peschanski at Institut National de la Sante et de la 
Recherche Medicale (INSERM), "the French equivalent of our NIH, has 
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been partially successful in treating Huntington's Chorea using fetal brain 
cells.,,166 Five patients suffering from Huntington's Chorea had fetal stem 
cells implanted on the sides of their brains. 167 Two years later, three 
patients showed significant improvement, although more research is needed 
to determine the possible effects of tampering with the brain during 
surgery. 168 
In Holland, Pharming, a Netherlands pharmaceutical company, and 
Infigen, a small Wisconsin company, successfully cloned seventeen 
Holstein cows in a combined effort with the Red Cross.169 The seventeen 
cows have identical genetic make-up because they are copies created in a 
lab dish from a modified cow embryo.l7O The goal of this research is to 
have the cows produce milk that naturally contains the proteins commonly 
used to treat hemophilia and other severe bleeding disorders. I7I If 
successful, Factor VIII, a costly fibrogen that stops traumatic bleeding in 
hemophiliacs, will be available for significantly less as a component in the 
milk. I72 Pharming and the Red Cross plan to petition the Food and Drug 
Administration for approval of the cows as manufacturers of drugs. 173 
The National Institutes of Health guidelines prohibit conjoining human 
and animal cells. Thus, federal funding is not available to Infigen or 
Advanced Cell Technology for this research. Although the unavailability 
of federal funding has not prevented all American companies from entering 
the global race of human stem cell research, more resources and highly 
skilled scientists like those working for the National Institutes of Health, 
are needed to bring the U.S. up-to-date to compete with other countries 
who had a head start. 
Prohibiting stem cell research in the United States or avoiding the 
controversy will not solve the ethical dilemma. The global phenomenon of 
advancing knowledge and finding cures through stem cell research will not 
be stopped. Had Congress been able to somehow prevent private 
companies from using human stem cells, those companies would have 
invested in research projects in foreign countries with more progressive 
ideologies. 174 The United States needs to take charge of the situation and 
move to the front of the line, before we are pushed out of the race 
altogether. 
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Without federal funding, the private sector will continue using human 
embryo stem cells for research, but it will be left to its own resources. The 
effect would be slow progress compared to the rest of the world. 
Absent the competitiveness of the U.S. in the race for this 
important technology, other countries would certainly be in 
position to reap the potentially enormous economic benefits should 
they become successful with their research. The effect of this 
might be likened to the type of dependency the U.S. now has on the 
Organization of the Petroleum Exporting Countries (OPEC) for its 
oil. 175 
V. CONCLUSION 
The potential medical and scientific benefits of human embryonic stem 
cell research are undeniable. However, ethical controversy surrounds the 
use of embryonic stem cells in research due to the special nature of the 
embryo. The most accepted ethical status of embryos seems to be that 
although embryos are not human persons with full rights and interests, they 
still deserve respect as a form of human life. Using embryos in research 
shows proper respect for them because the value of the embryo is 
demonstrated through enhancing the lives of suffering people. In addition, 
although adult stem cell research shows great promise, it does not hold as 
much potential as embryonic stem cell research, and thus cannot serve as a 
replacement. Creating embryos solely for research purposes cannot be a 
viable alternative since it further complicates the ethical debate. 
Considering the huge potential benefit for a great number of people and the 
lack of suitable alternatives with the same benefits, human embryonic stem 
cell research is more than sufficiently justified. 
Federal law currently prohibits funding any research that poses a risk to 
embryos. The controversy focuses on whether federal funding should be 
available for research with embryonic stem cells that are arguably not even 
embryos anymore. After a long turmoil of political, ethical, religious, and 
scientific disputes, President Bush announced that he would allow federal 
funding of embryonic stem cell research as long as the research uses pre-
existing stem cell lines and does not destroy any more embryos to extract 
the stem cells. Although any funding is a significant step toward realizing 
the full potential of embryonic stem cell research, this arbitrary restriction 
has been criticized for doing the bare minimum to side with the American 
popular majority. 
While controversy over federal funding availability for embryonic stem 
cell research continues, the private sector has been moving steadily forward 
with their privately funded research. Since federal regulations do not exist 
175. Paegel, supra note 133, at 1201-02. 
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'outside the funding' context, the private sector remains virtually 
unregulated. Despite economic restrictions hindering the private sector, 
privately funded researchers have managed to produce breakthroughs in the 
field. If embryonic stem cell research has to continue without federal 
funding, progress will be slow. 
Furthermore, because the scope of privately funded research is 
unlimited and proceeds without governmental oversight, the potential for 
abuse will likely increase. Withholding government funds from stem cell 
research does not eliminate the moral and ethical objections. On the other 
hand, federal funding confers a benefit of strictly enforced oversight 
processes and creates an incentive for other private research institutions to 
conform to federal ethical guidelines and regulations. With enormous 
resources available, from the federal government and top National Institutes 
of Health scientists at work, stem cell research will progress faster and 
more efficiently under federal oversight. 
The United States is currently lagging behind other countries in this 
stem cell research race. Considering the unlimited potential that stem cell 
research holds, we cannot delay progress because of divided ethical 
OpInIOns. It is impossible to obtain a unanimous opinion on such an 
important issue in a diverse society such as ours. The United States needs 
to move on and focus on catching up with the rest of the world before we 
are completely eliminated from the race. Federal funding provides a 
solution to potential abuse in the unregulated privately funded research and 
a way to keep up with the rest of the world while still ethically regUlating 
stem cell research. 
